Page 4 - Dan Schell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CEO Q&A: Dr. Aoife Brennan Source: Life Science Leader By Dan Schell, Editorial Director, Life Science Leader In our May 2019 issue, we featured Synlogic as our “Company To Watch,” and we interviewed Dr. Aoife Brennan, who has been president and CEO since May 2018. When we caught up with her in February 2021, she explained that, internally, the company is still focused on developing its “Synthetic Biotic” medicines for metabolic diseases, but it is also investigating ways to expand into other areas such as oncology and inflammatory bowel disease. For this Q&A, we wanted to find out ho...

A Q&A With A COVID-Era New CEO Source: Life Science Leader By Dan Schell, Editorial Director, Life Science Leader Becoming the CEO of a pharma company early in the COVID pandemic would be a big challenge for even a seasoned executive in this industry. Just ask David Horn Solomon, Ph.D., who took on the top role at Pharnext in April 2020. But for him, the challenge was two-fold, because the company recently had its Phase 3 trial data rejected by the FDA (for more on this part of the story, read my colleague Ed Miseta’s article on  Clinical Leader called, “A Clinical Setback Leads To A Tr...